Derma Pella Acne Care

Description

This product is a lightweight, water-based, alcohol-free gel formulated for topical application. It contains beta hydroxyl acid (BHA) in the form of salicylic acid, which effectively clears clogged pores, reduces blemishes, and minimizes the occurrence of blackheads and breakouts by dissolving excess sebum, making it particularly suitable for acne-prone skin.

In addition, the formulation includes tea tree oil, known for its soothing properties and ability to improve the appearance of skin marks. Niacinamide (Vitamin B3) is also present, contributing to the soothing and lightening of skin, visibly minimizing pores, and enhancing uneven skin tone while reducing dark spots and acne marks. Allantoin is included for its effective moisturizing properties, recognized for its gentle and non-irritating qualities.

The product is free from parabens, alcohol, and fragrance, ensuring a mild formulation suitable for sensitive skin types.

Uses and Indications

This drug is indicated for the treatment of acne, specifically to help clear existing acne lesions and reduce the formation of new blackheads and whiteheads.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to cleanse the skin thoroughly prior to the application of the product. After cleansing, the patient should dry their face completely before applying a thin layer of the product.

The recommended dosing frequency is one to three times daily. It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's tolerance and clinical response, the frequency may be gradually increased to two or three times daily as needed.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once a day or every other day to alleviate these side effects.

Contraindications

Use of this product is contraindicated in individuals with hypersensitivity to any of its components.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to discontinue use if excessive skin irritation develops or increases. In cases where irritation persists, it is recommended that patients consult with a physician or pharmacist for further evaluation and management.

Direct contact with the eyes must be avoided. In the event of accidental contact, patients should be instructed to rinse the eyes thoroughly with water to mitigate any potential adverse effects.

Side Effects

Patients may experience skin irritations, dryness, and redness, particularly when using another topical acne product concurrently. To minimize the risk of these adverse reactions, it is recommended that patients use only one product at a time.

This product is intended for external use only. Patients should discontinue use if excessive skin irritation develops or increases. In cases where irritation persists, it is advised to consult with a physician or pharmacist. Additionally, patients should avoid direct contact with the eyes; if contact occurs, they should rinse thoroughly with water.

Patients with hypersensitivity to any of the components of this product are contraindicated from its use.

Drug Interactions

The concurrent use of topical acne products may increase the likelihood of skin irritations, including dryness and redness. It is advisable to use only one topical acne product at a time to minimize the risk of irritation.

No specific drug or laboratory test interactions have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Derma Pella Acne Care (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children and to use it for external purposes only. Prior to application, the skin should be cleansed thoroughly, and the face should be dried. A thin layer of the product may be applied one to three times daily, starting with one application to minimize the risk of excessive skin drying. If excessive drying or peeling occurs, the frequency of application should be reduced to once daily or every other day.

In the event of excessive skin irritation, the product should be discontinued, and if irritation persists, consultation with a physician or pharmacist is recommended. Direct contact with the eyes should be avoided; if contact occurs, the eyes should be rinsed thoroughly with water.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Use is contraindicated in pregnancy due to potential risks to the fetus. Healthcare professionals should advise pregnant patients to avoid this product and consider alternative therapies that have a more established safety profile during pregnancy. Women of childbearing potential should be informed of these risks and the importance of effective contraception while using this product.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is paramount, and healthcare providers should ensure that the patient is stabilized. This may involve maintaining airway patency, providing supplemental oxygen, and monitoring vital signs continuously.

If specific antidotes or treatments are available for the substance involved, they should be administered as per established protocols. Additionally, healthcare professionals should consider contacting a poison control center for further guidance on the management of the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for ongoing management and treatment decisions.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

Postmarketing experience has identified skin irritations, dryness, and redness as adverse events reported voluntarily or through surveillance programs. These effects appear to be more likely to occur when the product is used concurrently with another topical acne treatment. In cases where irritation is observed, it is recommended that only one topical product be used at a time to mitigate these effects.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young children.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures below 30°C to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's quality.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to keep the product out of reach of children and to use it for external purposes only. Patients are advised to discontinue use if excessive skin irritation develops or worsens, and to consult a physician or pharmacist if irritation persists. Direct contact with the eyes should be avoided; in the event of contact, the eyes should be rinsed thoroughly with water.

Drug Information (PDF)

This file contains official product information for Derma Pella Acne Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)